Senior insider sale
Chief Medical Officer at UROGEN PHARMA LTD. — senior position signals high conviction
$511.5K
23.33K shares
What this filing means
SCHOENBERG MARK plans to sell 23.33K shares of UROGEN PHARMA LTD. valued at approximately $511.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/3/2026ACC: 0001976408-26-000031
Officer· Chief Medical Officer
Since Jan 2019
23.33K
Shares to sell
$511.5K
Approx. market value
13.33K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months3
RSU
N/A
1/31/2025
6.67KRSU
N/A
1/31/2024
3.33KRSU
N/A
1/31/2023
3.33KTotal acquired13.33K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/31/2025 | RSU N/A | 6.67K | — |
1/31/2024 | RSU N/A | 3.33K | — |
1/31/2023 | RSU N/A | 3.33K | — |
| Total | 13.33K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
10K
Market value
$250.0K
11/19/2025
Planned — Approximate Date
NasdaqPlanned
Units to sell
13.33K
Market value
$261.5K
2/2/2026
Total
Units
23.33K
Value
$511.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/19/2025 | 10K | $250.0K | — | Completed |
| Planned — Approximate Date | ||||
2/2/2026 | 13.33K | $261.5K | Nasdaq | Planned |
| Total | 23.33K | $511.5K | ||